Evidence map›Paper›PMID 42399458›Full record

SynthesisNeurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology2026

Limb apraxia in Parkinson's disease and atypical parkinsonian syndromes: a systematic review.

Evangelia Smaragdaki, Ioannis Stamelos, Magda Tsolaki, Nicolaos Scarmeas, Constantin Potagas, Leonidas Stefanis, Sokratis G Papageorgiou, Vasilios C Constantinides

Abstract readSystematic Review
In one paragraph

Synthesis in Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Evangelia SmaragdakiFirst Department of Neurology, Medical School, National and Kapodistrian University of Athens, Eginition Hospital, 11528, Athens, Greece.
Ioannis StamelosFirst Department of Neurology, Medical School, National and Kapodistrian University of Athens, Eginition Hospital, 11528, Athens, Greece.
Magda TsolakiLaboratory of Neurodegenerative Diseases, Center for Interdisciplinary Research and Innovation (CIRI), Aristotle University of Thessaloniki (AUTh), 54124, Thessaloniki, Greece.
Nicolaos ScarmeasFirst Department of Neurology, Medical School, National and Kapodistrian University of Athens, Eginition Hospital, 11528, Athens, Greece.
Constantin PotagasFirst Department of Neurology, Medical School, National and Kapodistrian University of Athens, Eginition Hospital, 11528, Athens, Greece.
Leonidas StefanisFirst Department of Neurology, Medical School, National and Kapodistrian University of Athens, Eginition Hospital, 11528, Athens, Greece.
Sokratis G Papageorgiou *First Department of Neurology, Medical School, National and Kapodistrian University of Athens, Eginition Hospital, 11528, Athens, Greece.
Vasilios C Constantinides *First Department of Neurology, Medical School, National and Kapodistrian University of Athens, Eginition Hospital, 11528, Athens, Greece. vassilis.kon@hotmail.com.ORCID http://orcid.org/0000-0001-7432-5009

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundEvidence regarding the clinical manifestations, disease-specific profiles and diagnostic significance of limb apraxia in Parkinson's disease and Atypical Parkinsonian Syndromes (APS) is limited.

objectivesThe present systematic review aims to consolidate current knowledge on limb apraxia across neurodegenerative disorders, including Parkinson's disease (PD), corticobasal syndrome (CBS), Progressive Supranuclear Palsy (PSP) and Multiple System Atrophy (MSA).

methodsA systematic literature review was conducted in accordance with PRISMA guidelines. Studies were included if they enrolled ≥ 10 patients in at least one of the patient groups and ≥ 10 control subjects with quantitative data on apraxic deficits. Risk of bias assessment was assessed.

resultsTwenty-two studies met inclusion criteria (PD n = 11; CBS n = 10; PSP n = 7; MSA n = 3). Across PD and APS, praxis assessment primarily involved gesture imitation, pantomime, action sequencing, actual tool use and measures of fine motor coordination. CBS demonstrated the most severe/widespread apraxic impairment, affecting both meaningless and meaningful (transitive and intransitive) gestures, as well as action sequencing and fine motor control. In PD, apraxic deficits were generally milder but shared overlapping features with CBS. Direct comparative studies between PD and CBS remain scarce. PSP was characterized by less frequent and predominantly sequence-related impairments, whereas findings in MSA were heterogeneous and less pronounced.

conclusionsLimb apraxia phenotypes differ across PD, CBS, PSP and MSA and may contribute to their differential diagnosis. Future research should adopt standardized, multimodal praxis assessment protocols in larger cohorts including all major neurodegenerative parkinsonian disorders, to facilitate the direct comparison of limb apraxia across these diseases.

Indexed as

ApraxiasExtremitiesParkinson DiseaseParkinsonian DisordersCorticobasal DegenerationHumansSupranuclear Palsy, ProgressiveApraxiaAtypical ParkinsonismCorticobasal syndromeMultiple system atrophyParkinson’s diseaseProgressive supranuclear palsy

Identifiers

PMID42399458
PMCPMC13331938

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.